- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Inherited Platelet Disorder in Canada
Total 9290 results
-
McMaster UniversityRecruiting
-
University Health Network, TorontoQueen's University; Canadian Blood ServicesNot yet recruitingBleeding | Cardiac Surgery | Cardiopulmonary Bypass | PlateletsCanada
-
GlaxoSmithKlineCompletedThrombocytopaeniaUnited States, Germany, Israel, Belgium, Finland, Ireland, Italy, Greece, India, Czech Republic, Hungary, Canada, Poland
-
CSL BehringRecruiting
-
Janssen Research & Development, LLCRecruitingInherited Retinal DiseasesUnited States, Korea, Republic of, Canada, Spain, Denmark, Germany, France, Italy, Israel, Austria, United Kingdom
-
Korea University Anam HospitalRecruitingPlatelet Activation | Hemodialysis Fistula ThrombosisKorea, Republic of
-
Hoffmann-La RocheRecruitingHemophilia ASpain, Canada, United States, New Zealand, Italy, Poland
-
Hamilton Health Sciences CorporationHoffmann-La RocheCompletedPurpura, Thrombocytopenic, IdiopathicCanada
-
Ottawa Hospital Research InstituteCanadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR)... and other collaboratorsActive, not recruitingPrimary Myelofibrosis | Venous Thromboembolism (VTE) | Polycythemia Vera (PV) | Essential Thrombocythemia (ET) | JAK2 Mutation | Myeloproliferative Neoplasm (MPN)Canada
-
London Health Sciences CentreWithdrawnPurpura, Thrombotic Thrombocytopenic | Hemolytic Uremic SyndromeCanada
-
Academisch Medisch Centrum - Universiteit van Amsterdam...UnknownHemophiliaNetherlands, Austria, Australia, Belgium, Canada, Finland, Germany, Italy, Spain, United Kingdom
-
Mount Sinai Hospital, CanadaActive, not recruitingThrombocytopenia | Hematologic Malignancy | Venous Thromboembolic Disease | Thrombosis, Venous | Bleeding HemorrhageCanada
-
University Health Network, TorontoNovartis PharmaceuticalsCompletedMyelofibrosis (MF) | Myeloproliferative Neoplasms (MPN) | Polycythemia Vera (PV) | Essential Thrombocythemia (ET)Canada
-
Janssen Research & Development, LLCRecruitingNeoplasms | Myeloproliferative Disorders | Essential Thrombocythemia | MyelofibrosisUnited States, Spain, France, Canada
-
Spark TherapeuticsCompletedHematologic Diseases | Hemophilia A | Blood Coagulation Disorders, Inherited | Coagulation Protein Disorders | Hemorrhagic Disorders | Genetic Diseases, Inborn | Genetic Diseases, X-Linked | Blood Coagulation Disorder | Factor VIII DeficiencyUnited States, Australia, Thailand, Canada
-
Aspen Global IncorporatedTerminatedHeparin-induced ThrombocytopeniaUnited States, Bosnia and Herzegovina, Canada, France, Germany, Italy, Poland, Russian Federation, Serbia
-
SanofiBristol-Myers SquibbCompletedBlood Platelet Disorders | Congenital Heart DefectsUnited States, France, Canada, Germany, Italy, Belgium
-
Spark TherapeuticsActive, not recruitingHemophilia AUnited States, Canada, Australia
-
Swedish Orphan BiovitrumBioverativ Therapeutics Inc.CompletedHemophilia AIreland, United Kingdom, Germany, United States, Canada, Slovenia, Sweden
-
Baxalta now part of ShireCompletedHemophilia AUnited States, Canada, Puerto Rico
-
Harokopio UniversityNational and Kapodistrian University of Athens; University of PeloponneseUnknownInflammation | Oxidative Stress | Postprandial Hyperglycemia | Diabetes Mellitus, Adult-Onset | Platelet Dysfunction | LipidemiaGreece
-
rEVO BiologicsCompletedAntithrombin III DeficiencyUnited States, France, United Kingdom, Germany, Canada, Austria, Australia, Italy
-
Baxalta now part of ShireBaxter Innovations GmbHTerminatedHemophilia APoland, United States, Bulgaria, Serbia, Canada, Russian Federation, Germany, Netherlands, Lithuania, Czechia, Austria, Spain
-
CSL BehringCompletedCongenital Fibrinogen DeficiencyUnited States, Canada
-
Genzyme, a Sanofi CompanyActive, not recruitingHemophiliaCanada, Italy, Turkey, Spain, United States, India
-
University of CalgaryWithdrawn
-
OctapharmaCompletedSevere Hemophilia AUnited States, France, Canada, United Kingdom, India, Georgia, Moldova, Republic of, Poland, Ukraine
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Congenital FXIII DeficiencyFrance, United States, Israel, Spain, Switzerland, Germany, Canada, Japan, United Kingdom, Italy, Finland, Austria
-
Spark TherapeuticsCompletedHemophilia AUnited States, Australia, Canada, Israel, Thailand
-
Merck Sharp & Dohme LLCCompletedHIV Infections | Hemophilia ACanada, United States
-
PfizerCompletedHemophilia BCanada, Singapore, Turkey, Croatia, Korea, Republic of, Mexico, Poland, Bulgaria, Malaysia
-
Baxalta now part of ShireCompletedAcquired Hemophilia AUnited States, Canada, India, United Kingdom
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia BUnited States, Canada, United Kingdom, France, Malaysia, Brazil, Croatia, Germany, Italy, Japan, Taiwan
-
McMaster UniversityGlaxoSmithKline; Novartis; Hamilton Health Sciences CorporationCompletedImmune Thrombocytopenic PurpuraCanada, Netherlands
-
Baxalta now part of ShireBaxalta Innovations GmbH, now part of ShireTerminatedHemophilia ANetherlands, Spain, Italy, Turkey, Bulgaria, United States, Canada, Germany, Norway, Poland, Russian Federation, South Africa
-
BayerCompletedBlood Coagulation Disorders | Hematologic DiseaseUnited States, Germany, United Kingdom, Canada
-
CSL BehringCompletedHemophilia BGermany, Australia, Italy, Israel, Czech Republic, Spain, France, Canada, Austria, Russian Federation
-
PfizerActive, not recruitingHemophilia BUnited States, Canada, Australia, Turkey
-
Sierra Oncology, Inc.CompletedPrimary Myelofibrosis | Post-Polycythemia Vera Myelofibrosis | Post-Essential Thrombocythemia MyelofibrosisUnited States, Canada, Australia
-
Regeneron PharmaceuticalsRecruitingHemophilia BUnited States, Germany, United Kingdom, Canada
-
Sierra Oncology, Inc.CompletedPrimary Myelofibrosis | Post-Polycythemia Vera | Post-Essential Thrombocythemia MyelofibrosisUnited States, Canada
-
BayerActive, not recruitingHemophilia ACanada, Japan, Spain, United States, Germany, Sweden, Belgium, Brazil, Greece, Italy, Netherlands, Taiwan, Denmark, Kuwait, Saudi Arabia, United Arab Emirates, Norway, Colombia, Switzerland, Slovenia
-
Sierra Oncology, Inc.CompletedPrimary Myelofibrosis | Post-Polycythemia Vera Myelofibrosis | Post-Essential Thrombocythemia MyelofibrosisUnited States, Canada, Australia
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia AFrance, United States, Switzerland, Malaysia, Brazil, Canada, Japan, United Kingdom, Israel, Portugal, Ukraine, Greece, Lithuania, Puerto Rico, Turkey, Italy
-
Hoffmann-La RocheCompletedHemophilia ACanada, Australia, Belgium, India, Germany, Israel, Italy, Spain, Colombia, United Kingdom, Netherlands, Saudi Arabia, Hungary, Guatemala, Russian Federation, Poland, Switzerland, Finland, Panama, Brazil, Mexico, Portugal, Romania, Sw...
-
PharmaEssentiaRecruitingEssential ThrombocythemiaUnited States, Canada
-
Baxalta now part of ShireCompletedHemophilia AUnited States, France, Austria, United Kingdom, Germany, Belgium, Canada, Italy, Sweden
-
PfizerCompletedHemophilia BUnited States, Spain, Croatia, Serbia, Russian Federation, Canada, Hungary, Italy, Romania
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With InhibitorsSlovakia, Spain, Argentina, Germany, Croatia, Italy, Canada, United Kingdom, Ireland, Sweden, France, United States, Czech Republic, Switzerland
-
Sierra Oncology, Inc.TerminatedPolycythemia Vera | Essential ThrombocythemiaUnited States, France, Germany, Canada, Australia